Local Calcium Signaling in Pulmonary Arteries
肺动脉中的局部钙信号传导
基本信息
- 批准号:6824048
- 负责人:
- 金额:$ 32.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-12-15 至 2006-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
EXCEED THE SPACE PROVIDED. Local Ca2+ release transients, or "Ca2+ sparks", originated from ryanodine receptors on sarcoplasmic receptors have been identified in cardiac, skeletal, and smooth muscles. In systemic vascular smooth muscles, they have been implicated as a feedback modulator of membrane potential by increasing local [Ca2+], activating nearby Ca2+-activated K+ (KCa) channels, leading to membrane hyperpolarization and vasodilation. Recently, we have identified and characterized Ca2+ sparks in rat intralobar pulmonary arterial smooth muscle cells (PASMCs). In contrast to systemic vascular smooth muscle, activation of Ca2+ spark in PASMCs causes membrane depolarization. Endothelin-1 (ET-1), a major mediator of acute and chronic hypoxia induced pulmonary vasoconstriction, causes dramatic increase in Ca2+ spark frequency, which can be blocked by ET-A receptor antagonist, and non-selective cation channels. Inhibition of Ca2+ sparks with ryanodine significantly attenuated the ET-1 induced contraction of pulmonary arteries. Enhancement of Ca2+ spark by ET-1 is evident even at a threshold concentration (10-10 M), which at the best cause minimal contraction but is capable of potentiating hypoxic pulmonary vasoconstriction and contraction induced by other vasoconstrictor. Moreover, norepinephrine, which activates the PLC/PKC pathway similar to ET-1, causes the opposite effect of inhibiting Ca2+ sparks in PASMCs. Based on these novel findings, we propose that Ca2+ spark in PASMCs promote vasoconstriction, and vasoconstrictors modulate Ca2+ sparks through specific receptor dependent mechanisms. To test this hypotheses, we will apply a combination of state-of-the-art techniques including whole-cell patch clamp, laser-scanning confocal microscopy, and UV-pulse laser flash photolysis, RT-PCR, and gene-knockout with antisense oligonucleotide to examine if Ca2+ spark of PASMCs promotes vasoconstriction by (i) inducing membrane depolarization, (ii) providing Ca2+ for direct myofilament activation, and/or (iii) potentiating the contractile effects of other physiological stimuli. We will also characterize and identify signaling pathways for agonist- induced Ca2+ sparks activation, and determine the molecular identity and functional role of non-selective cation channels in Ca2+ spark actiivation. This project will provide important information on the unique control of pulmonary circulation by subcellular local Ca2+ signaling. PERFORMANCE SITE ========================================Section End===========================================
超过提供的空间。局部Ca2+释放瞬变或“ Ca2+火花”起源于肌浆受体上的ryanodine受体,在心脏,骨骼和光滑的肌肉中鉴定出来。在全身性血管平滑肌肉中,通过增加局部[Ca2+],激活附近Ca2+活化的K+(KCA)通道,从而导致膜超极化和血管舒张,将它们与膜电位的反馈调节剂有关。最近,我们已经确定并表征了大鼠肺内动脉平滑肌细胞(PASMC)中的Ca2+火花。与全身血管平滑肌相反,PASMC中Ca2+火花的激活导致膜去极化。内皮素-1(ET-1)是急性和慢性缺氧的主要介质引起的肺血管收缩,会导致Ca2+火花频率的急剧增加,可以通过ET-A受体拮抗剂和非选择性阳离子通道阻止。 ryanodine对Ca2+火花的抑制显着减弱了ET-1诱导的肺动脉收缩。即使在阈值浓度(10-10 m)中,通过ET-1增强Ca2+火花也很明显,这最佳导致最小收缩,但能够增强其他血管收缩剂引起的低氧肺血管收缩和收缩。此外,激活与ET-1相似的PLC/PKC途径的去甲肾上腺素会导致抑制PASMC中Ca2+火花的相反作用。基于这些新的发现,我们提出PASMC中的Ca2+火花促进血管收缩,血管收缩器通过特定受体依赖机制调节Ca2+火花。为了检验这一假设,我们将采用最先进的技术组合,包括全细胞贴片夹,激光扫描的共聚焦显微镜和UV-Pulse激光闪光光解,RT-PCR和Gene-nockout和ant gene-nockout用反义核苷酸进行反义核苷酸,以检查pasmcys vasemctions vasbrane vasemctional vasextrion(Ii spasks sprandiation(II)(ii)(II)(ii spasks)(ii spasks sprance insoctions vasextription(II)(II)(II)(II)(II)(II)(II)(II)(II)。为直接肌丝激活提供Ca2+,和/或(iii)增强其他生理刺激的收缩作用。我们还将表征和识别激动剂诱导的Ca2+火花激活的信号传导途径,并确定非选择性阳离子通道在Ca2+火花作用中的分子身份和功能作用。该项目将通过亚细胞局部CA2+信号传导提供有关肺循环独特控制的重要信息。表演站点=============================================================================================
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES SK SHAM其他文献
JAMES SK SHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES SK SHAM', 18)}}的其他基金
Pathologic Roles of TRP channels in Idiopathic Pulmonary Arterial Hypertension
TRP 通道在特发性肺动脉高压中的病理作用
- 批准号:
8518455 - 财政年份:2012
- 资助金额:
$ 32.7万 - 项目类别:
Pathologic Roles of TRP channels in Idiopathic Pulmonary Arterial Hypertension
TRP 通道在特发性肺动脉高压中的病理作用
- 批准号:
8354486 - 财政年份:2012
- 资助金额:
$ 32.7万 - 项目类别:
Ca regulation in chronic hypoxic pulmonary hypertension
慢性缺氧性肺动脉高压的钙离子调节
- 批准号:
6867425 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
Ca regulation in chronic hypoxic pulmonary hypertension
慢性缺氧性肺动脉高压的钙离子调节
- 批准号:
6706704 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
Ca regulation in chronic hypoxic pulmonary hypertension
慢性缺氧性肺动脉高压的钙离子调节
- 批准号:
7019165 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
Ca2+ Regulation in Chronic Hypoxic Pulmonary Hypertention
慢性缺氧性肺动脉高压中的 Ca2 调节
- 批准号:
8112656 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
Ca2+ Regulation in Chronic Hypoxic Pulmonary Hypertention
慢性缺氧性肺动脉高压中的 Ca2 调节
- 批准号:
7896532 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
Ca2+ Regulation in Chronic Hypoxic Pulmonary Hypertention
慢性缺氧性肺动脉高压中的 Ca2 调节
- 批准号:
7728590 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
Ca regulation in chronic hypoxic pulmonary hypertension
慢性缺氧性肺动脉高压的钙离子调节
- 批准号:
7185136 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
Ca2+ Regulation in Chronic Hypoxic Pulmonary Hypertention
慢性缺氧性肺动脉高压中的 Ca2 调节
- 批准号:
8309857 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
相似国自然基金
光控钙通道调节脊髓性肌萎缩症细胞骨架和核糖体的功能研究
- 批准号:82302108
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Cav3.1钙通道介导的Sphk/S1P信号在帕金森病模型中的作用及机制研究
- 批准号:82371265
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于T型钙通道功能探索延胡索治疗疼痛抑郁共病的作用机制
- 批准号:82374058
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
T型钙通道CaV3.3蛋白介导应力促生长板软骨细胞肥大化致CAM畸形的机制研究
- 批准号:82372365
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
钙通道及钙信号的机制分析与理性设计
- 批准号:32371301
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
相似海外基金
Ryanodine Receptor Regulation of Sensory Neuron Function
Ryanodine 受体对感觉神经元功能的调节
- 批准号:
6849129 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
Altered Glial Calcium Signaling in Neurodegeneration
神经退行性变中神经胶质钙信号的改变
- 批准号:
7026973 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
Altered Glial Calcium Signaling in Neurodegeneration
神经退行性变中神经胶质钙信号的改变
- 批准号:
6758246 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别:
Altered Glial Calcium Signaling in Neurodegeneration
神经退行性变中神经胶质钙信号的改变
- 批准号:
6864864 - 财政年份:2004
- 资助金额:
$ 32.7万 - 项目类别: